Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Legochem Biosciences Inc patents


Recent patent applications related to Legochem Biosciences Inc. Legochem Biosciences Inc is listed as an Agent/Assignee. Note: Legochem Biosciences Inc may have other listings under different names/spellings. We're not affiliated with Legochem Biosciences Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Legochem Biosciences Inc-related inventors


 new patent  Compositions and methods for inhibiting beta-lactamase

Substituted dihydroisoxazole derivatives useful as inhibitors of β-lactamases are provided. The invention further provides medical uses of substituted dihydroisoxazole derivatives, for example, as antibacterial agents.. ... Legochem Biosciences Inc

Antibody-active agent conjugates and methods of use

The invention provides protein-active agent conjugates having an amino acid motif that can be recognized by an isoprenoid transferase. The invention also provides compositions containing the conjugates. ... Legochem Biosciences Inc

Novel crystalline form of 5-chloro-n-(methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same

The present invention relates to a novel crystalline form of 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and a pharmaceutical composition containing the same. The novel crystalline form of a compound according to the present invention exhibits excellent stability even in high-temperature and humidity environments, and thus can be favorably used to prevent or treat diseases, such as thrombosis, myocardial infarction, atherosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.. ... Legochem Biosciences Inc

Compositions and methods for inhibiting beta-lactamase

Substituted dihydroisoxazole derivatives useful as inhibitors of β-lactamases are provided. The invention further provides medical uses of substituted dihydroisoxazole derivatives, for example, as antibacterial agents.. ... Legochem Biosciences Inc

Compounds comprising self-immolative group

Provided are methods of use of compounds comprising a self-immolative group, which compounds may include a protein (for example, an oligopeptide, a polypeptide, an antibody, or the like) having substrate-specificity for a target and an active agent (for example, a drug, a toxin, a ligand, a detection probe, or the like) having a specific function or activity.. . ... Legochem Biosciences Inc

Compositions and methods related to anti-egfr antibody drug conjugates

In some aspects, the invention relates to an antibody-drug conjugate, comprising an anti-epidermal growth factor receptor (“egfr”) antibody; a linker; and an active agent. The antibody-drug conjugate may comprise a self-immolative group. ... Legochem Biosciences Inc

Compositions and methods related to anti-cd19 antibody drug conjugates

In some aspects, the invention relates to an antibody-drug conjugate, comprising an anti-cd19 antibody; a linker; and an active agent. The antibody-drug conjugate may comprise a self-immolative group. ... Legochem Biosciences Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Legochem Biosciences Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Legochem Biosciences Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###